MY Xuan, SG Piao, J Ding, QY Nan, MH Piao… - Frontiers in …, 2022 - frontiersin.org
Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, offers renoprotection in diabetes.
However, potential for use in nondiabetic kidney disease remains unknown. Herein, we …